PFE logo

Pfizer Inc. (PFE) Cash from investing

annual CFI:

$2.65B+$34.93B(+108.22%)
December 31, 2024

Summary

  • As of today (August 23, 2025), PFE annual cash flow from investing activities is $2.65 billion, with the most recent change of +$34.93 billion (+108.22%) on December 31, 2024.
  • During the last 3 years, PFE annual CFI has risen by +$25.20 billion (+111.76%).
  • PFE annual CFI is now -56.91% below its all-time high of $6.15 billion, reached on December 31, 2012.

Performance

PFE Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

quarterly CFI:

$3.95B+$677.00M(+20.68%)
June 29, 2025

Summary

  • As of today (August 23, 2025), PFE quarterly cash flow from investing activities is $3.95 billion, with the most recent change of +$677.00 million (+20.68%) on June 29, 2025.
  • Over the past year, PFE quarterly CFI has dropped by -$649.00 million (-14.11%).
  • PFE quarterly CFI is now -59.13% below its all-time high of $9.67 billion, reached on March 1, 2018.

Performance

PFE quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

TTM CFI:

$3.54B-$649.00M(-15.47%)
June 29, 2025

Summary

  • As of today (August 23, 2025), PFE TTM cash flow from investing activities is $3.54 billion, with the most recent change of -$649.00 million (-15.47%) on June 29, 2025.
  • Over the past year, PFE TTM CFI has increased by +$7.32 billion (+193.88%).
  • PFE TTM CFI is now -42.40% below its all-time high of $6.15 billion, reached on December 31, 2012.

Performance

PFE TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

PFE Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+108.2%-14.1%+193.9%
3 y3 years+111.8%+134.9%+115.1%
5 y5 years+167.2%+130.4%+115.6%

PFE Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+108.2%-14.1%+115.5%-15.5%+110.5%
5 y5-yearat high+108.2%-52.6%+115.5%-15.5%+110.5%
alltimeall time-56.9%+108.2%-59.1%+115.5%-42.4%+110.5%

PFE Cash from investing History

DateAnnualQuarterlyTTM
Jun 2025
-
$3.95B(+20.7%)
$3.54B(-15.5%)
Mar 2025
-
$3.27B(-301.7%)
$4.19B(+58.1%)
Dec 2024
$2.65B(-108.2%)
-$1.62B(-21.1%)
$2.65B(-139.5%)
Sep 2024
-
-$2.06B(-144.7%)
-$6.72B(+78.0%)
Jun 2024
-
$4.60B(+165.6%)
-$3.78B(-88.8%)
Mar 2024
-
$1.73B(-115.8%)
-$33.86B(+4.9%)
Dec 2023
-$32.28B(+63.5%)
-$11.00B(-1338.3%)
-$32.28B(+25.6%)
Sep 2023
-
$888.00M(-103.5%)
-$25.69B(-17.6%)
Jun 2023
-
-$25.48B(-868.8%)
-$31.17B(+83.4%)
Mar 2023
-
$3.31B(-175.2%)
-$17.00B(-13.9%)
Dec 2022
-$19.74B(-12.4%)
-$4.41B(-3.9%)
-$19.74B(+10.2%)
Sep 2022
-
-$4.59B(-59.5%)
-$17.92B(-23.4%)
Jun 2022
-
-$11.31B(-2095.2%)
-$23.41B(+15.7%)
Mar 2022
-
$567.00M(-121.9%)
-$20.23B(-10.3%)
Dec 2021
-$22.55B(+427.9%)
-$2.59B(-74.3%)
-$22.55B(+93.9%)
Sep 2021
-
-$10.08B(+23.8%)
-$11.63B(+983.9%)
Jun 2021
-
-$8.14B(+365.8%)
-$1.07B(-82.0%)
Mar 2021
-
-$1.75B(-121.0%)
-$5.95B(+39.2%)
Dec 2020
-$4.27B(+8.3%)
$8.33B(+1631.8%)
-$4.27B(-72.3%)
Sep 2020
-
$481.00M(-103.7%)
-$15.43B(-31.9%)
Jun 2020
-
-$13.01B(>+9900.0%)
-$22.68B(+96.0%)
Mar 2020
-
-$71.00M(-97.5%)
-$11.57B(+193.2%)
Dec 2019
-$3.94B(-187.2%)
-$2.83B(-58.1%)
-$3.94B(+110.3%)
Sep 2019
-
-$6.76B(+255.4%)
-$1.88B(-194.7%)
Jun 2019
-
-$1.90B(-125.2%)
$1.98B(-17.8%)
Mar 2019
-
$7.55B(-1088.2%)
$2.41B(-46.8%)
Dec 2018
$4.53B(-195.5%)
-$764.00M(-73.7%)
$4.53B(+785.5%)
Sep 2018
-
-$2.90B(+97.0%)
$511.00M(+20.8%)
Jun 2018
-
-$1.47B(-115.2%)
$423.00M(+172.9%)
Mar 2018
-
$9.67B(-302.3%)
$155.00M(-103.3%)
Dec 2017
-$4.74B(-39.3%)
-$4.78B(+59.7%)
-$4.74B(+54.4%)
Sep 2017
-
-$2.99B(+71.8%)
-$3.07B(-31.2%)
Jun 2017
-
-$1.74B(-136.5%)
-$4.46B(-39.7%)
Mar 2017
-
$4.77B(-253.6%)
-$7.39B(-5.3%)
Dec 2016
-$7.81B(+162.1%)
-$3.11B(-29.1%)
-$7.81B(+12.7%)
Sep 2016
-
-$4.38B(-6.3%)
-$6.93B(-11.1%)
Jun 2016
-
-$4.68B(-207.4%)
-$7.79B(+49.3%)
Mar 2016
-
$4.36B(-295.7%)
-$5.22B(+75.0%)
Dec 2015
-$2.98B(-47.3%)
-$2.23B(-57.6%)
-$2.98B(+31.3%)
Sep 2015
-
-$5.24B(+149.1%)
-$2.27B(-618.3%)
Jun 2015
-
-$2.10B(-131.9%)
$438.00M(-57.7%)
Mar 2015
-
$6.59B(-535.4%)
$1.04B(-118.3%)
Dec 2014
-$5.65B(-46.8%)
-$1.51B(-40.3%)
-$5.65B(+39.3%)
Sep 2014
-
-$2.54B(+68.2%)
-$4.06B(+90.1%)
Jun 2014
-
-$1.51B(+1437.8%)
-$2.14B(-1131.9%)
Mar 2014
-
-$98.00M(-222.5%)
$207.00M(-101.9%)
Dec 2013
-$10.63B(-272.7%)
$80.00M(-113.1%)
-$10.63B(+174.7%)
Sep 2013
-
-$611.00M(-173.1%)
-$3.87B(+10.4%)
Jun 2013
-
$836.00M(-107.6%)
-$3.50B(-33.0%)
Mar 2013
-
-$10.93B(-259.9%)
-$5.23B(-184.9%)
Dec 2012
$6.15B(+233.9%)
$6.84B(-2868.0%)
$6.15B(+2749.1%)
Sep 2012
-
-$247.00M(-72.2%)
$216.00M(-68.1%)
Jun 2012
-
-$887.00M(-296.7%)
$678.00M(-64.8%)
Mar 2012
-
$451.00M(-49.8%)
$1.93B(-12.5%)
Dec 2011
$1.84B(-474.6%)
$899.00M(+318.1%)
$2.20B(-150.6%)
Sep 2011
-
$215.00M(-40.4%)
-$4.34B(-48.5%)
Jun 2011
-
$361.00M(-50.2%)
-$8.44B(-7.9%)
Mar 2011
-
$725.00M(-112.8%)
-$9.16B(+1762.0%)
Dec 2010
-$492.00M(-98.4%)
-$5.64B(+45.5%)
-$492.00M(-162.6%)
Sep 2010
-
-$3.88B(+974.8%)
$786.00M(-82.0%)
Jun 2010
-
-$361.00M(-103.8%)
$4.37B(-153.0%)
Mar 2010
-
$9.39B(-315.1%)
-$8.24B(-73.6%)
Dec 2009
-$31.27B(+143.6%)
-$4.37B(+1365.4%)
-$31.27B(+5.3%)
Sep 2009
-
-$298.00M(-97.7%)
-$29.68B(-2.7%)
Jun 2009
-
-$12.97B(-4.8%)
-$30.49B(+45.3%)
Mar 2009
-
-$13.63B(+390.4%)
-$20.98B(+63.5%)
Dec 2008
-$12.84B(-1714.5%)
-$2.78B(+151.1%)
-$12.84B(-0.1%)
Sep 2008
-
-$1.11B(-68.0%)
-$12.85B(+9.9%)
Jun 2008
-
-$3.46B(-36.8%)
-$11.70B(+30.6%)
Mar 2008
-
-$5.48B(+95.9%)
-$8.96B(-1227.0%)
Dec 2007
$795.00M(-84.4%)
-$2.80B(-6055.3%)
$795.00M(-80.3%)
Sep 2007
-
$47.00M(-106.5%)
$4.03B(-6.9%)
Jun 2007
-
-$724.00M(-117.0%)
$4.33B(+9.8%)
Mar 2007
-
$4.27B(+881.8%)
$3.94B(-22.7%)
Dec 2006
$5.10B
$435.00M(+26.5%)
$5.10B(-263.9%)
Sep 2006
-
$344.00M(-131.0%)
-$3.11B(-36.7%)
DateAnnualQuarterlyTTM
Jun 2006
-
-$1.11B(-120.4%)
-$4.92B(-261.5%)
Mar 2006
-
$5.43B(-169.8%)
$3.04B(-160.0%)
Dec 2005
-$5.07B(-46.2%)
-$7.78B(+432.1%)
-$5.07B(<-9900.0%)
Sep 2005
-
-$1.46B(-121.3%)
$18.00M(-98.8%)
Jun 2005
-
$6.86B(-355.2%)
$1.52B(-118.1%)
Mar 2005
-
-$2.69B(-0.1%)
-$8.39B(-11.0%)
Dec 2004
-$9.42B(-294.2%)
-$2.69B(-7367.6%)
-$9.42B(+61.5%)
Sep 2004
-
$37.00M(-101.2%)
-$5.83B(+1.2%)
Jun 2004
-
-$3.05B(-18.1%)
-$5.76B(-292.2%)
Mar 2004
-
-$3.72B(-513.9%)
$3.00B(-38.2%)
Dec 2003
$4.85B(-211.8%)
$899.00M(+748.1%)
$4.85B(+44.0%)
Sep 2003
-
$106.00M(-98.1%)
$3.37B(+36.4%)
Jun 2003
-
$5.72B(-405.8%)
$2.47B(-148.1%)
Mar 2003
-
-$1.87B(+220.0%)
-$5.13B(+18.3%)
Dec 2002
-$4.34B(-40.2%)
-$584.00M(-26.4%)
-$4.34B(-25.7%)
Sep 2002
-
-$793.00M(-57.9%)
-$5.84B(-9.8%)
Jun 2002
-
-$1.89B(+75.2%)
-$6.47B(-8.5%)
Mar 2002
-
-$1.08B(-48.3%)
-$7.07B(-2.5%)
Dec 2001
-$7.25B(+93.3%)
-$2.08B(+46.3%)
-$7.25B(+30.4%)
Sep 2001
-
-$1.42B(-42.7%)
-$5.56B(-6.2%)
Jun 2001
-
-$2.49B(+97.5%)
-$5.93B(+20.1%)
Mar 2001
-
-$1.26B(+220.4%)
-$4.94B(+31.5%)
Dec 2000
-$3.75B(+35.6%)
-$393.00M(-78.1%)
-$3.75B(+6.0%)
Sep 2000
-
-$1.79B(+19.9%)
-$3.54B(+28.6%)
Jun 2000
-
-$1.49B(+1892.0%)
-$2.75B(+51.3%)
Mar 2000
-
-$75.00M(-58.8%)
-$1.82B(-34.2%)
Dec 1999
-$2.77B(+726.3%)
-$182.00M(-81.9%)
-$2.77B(-32.5%)
Sep 1999
-
-$1.00B(+79.1%)
-$4.10B(+151.5%)
Jun 1999
-
-$560.00M(-45.3%)
-$1.63B(+7.3%)
Mar 1999
-
-$1.02B(-32.4%)
-$1.52B(+353.4%)
Dec 1998
-$335.00M(-67.2%)
-$1.51B(-203.2%)
-$335.00M(-134.7%)
Sep 1998
-
$1.47B(-426.7%)
$966.00M(-244.0%)
Jun 1998
-
-$449.00M(-378.9%)
-$671.00M(+42.5%)
Mar 1998
-
$161.00M(-175.6%)
-$471.00M(-51.1%)
Dec 1997
-$1.02B(+9.1%)
-$213.00M(+25.3%)
-$963.00M(+124.5%)
Sep 1997
-
-$170.00M(-31.7%)
-$429.00M(-61.5%)
Jun 1997
-
-$249.00M(-24.8%)
-$1.11B(-23.0%)
Mar 1997
-
-$331.00M(-203.1%)
-$1.45B(+70.1%)
Dec 1996
-$937.00M(-60.0%)
$321.00M(-137.6%)
-$850.00M(-44.2%)
Sep 1996
-
-$854.00M(+46.7%)
-$1.52B(+116.8%)
Jun 1996
-
-$582.00M(-319.6%)
-$702.50M(+69.8%)
Mar 1996
-
$265.00M(-175.2%)
-$413.70M(-82.3%)
Dec 1995
-$2.34B(+178.8%)
-$352.20M(+957.7%)
-$2.34B(+7.8%)
Sep 1995
-
-$33.30M(-88.6%)
-$2.17B(-5.8%)
Jun 1995
-
-$293.20M(-82.4%)
-$2.31B(-4.7%)
Mar 1995
-
-$1.66B(+809.3%)
-$2.42B(+188.2%)
Dec 1994
-$840.30M(+326.8%)
-$183.00M(+9.8%)
-$840.30M(+47.3%)
Sep 1994
-
-$166.60M(-59.1%)
-$570.30M(+31.9%)
Jun 1994
-
-$407.80M(+391.9%)
-$432.50M(-2199.5%)
Mar 1994
-
-$82.90M(-195.3%)
$20.60M(-110.5%)
Dec 1993
-$196.90M(-150.5%)
$87.00M(-402.1%)
-$196.90M(-413.0%)
Sep 1993
-
-$28.80M(-163.6%)
$62.90M(-169.5%)
Jun 1993
-
$45.30M(-115.1%)
-$90.50M(+3.2%)
Mar 1993
-
-$300.40M(-186.6%)
-$87.70M(-122.5%)
Dec 1992
$389.90M(-411.4%)
$346.80M(-290.3%)
$389.90M(+124.6%)
Sep 1992
-
-$182.20M(-478.8%)
$173.60M(-17.4%)
Jun 1992
-
$48.10M(-72.9%)
$210.10M(-555.7%)
Mar 1992
-
$177.20M(+35.8%)
-$46.10M(-63.2%)
Dec 1991
-$125.20M(-61.9%)
$130.50M(-189.6%)
-$125.20M(-46.1%)
Sep 1991
-
-$145.70M(-30.0%)
-$232.10M(-32.6%)
Jun 1991
-
-$208.10M(-312.1%)
-$344.60M(+4.7%)
Mar 1991
-
$98.10M(+315.7%)
-$329.10M(+0.0%)
Dec 1990
-$329.00M(-37.7%)
$23.60M(-109.1%)
-$329.00M(-6.7%)
Sep 1990
-
-$258.20M(+34.1%)
-$352.60M(+273.5%)
Jun 1990
-
-$192.60M(-296.1%)
-$94.40M(-196.1%)
Mar 1990
-
$98.20M
$98.20M
Dec 1989
-$528.50M(-35.2%)
-
-
Dec 1988
-$815.10M(+162.5%)
-
-
Dec 1987
-$310.50M(+58.3%)
-
-
Dec 1986
-$196.10M(-74.8%)
-
-
Dec 1985
-$778.30M(+571.5%)
-
-
Dec 1984
-$115.90M(-52.7%)
-
-
Dec 1983
-$245.00M(-2.1%)
-
-
Dec 1982
-$250.30M(-5.9%)
-
-
Dec 1981
-$266.10M(+56.4%)
-
-
Dec 1980
-$170.10M
-
-

FAQ

  • What is Pfizer Inc. annual cash flow from investing activities?
  • What is the all time high annual CFI for Pfizer Inc.?
  • What is Pfizer Inc. annual CFI year-on-year change?
  • What is Pfizer Inc. quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Pfizer Inc.?
  • What is Pfizer Inc. quarterly CFI year-on-year change?
  • What is Pfizer Inc. TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Pfizer Inc.?
  • What is Pfizer Inc. TTM CFI year-on-year change?

What is Pfizer Inc. annual cash flow from investing activities?

The current annual CFI of PFE is $2.65B

What is the all time high annual CFI for Pfizer Inc.?

Pfizer Inc. all-time high annual cash flow from investing activities is $6.15B

What is Pfizer Inc. annual CFI year-on-year change?

Over the past year, PFE annual cash flow from investing activities has changed by +$34.93B (+108.22%)

What is Pfizer Inc. quarterly cash flow from investing activities?

The current quarterly CFI of PFE is $3.95B

What is the all time high quarterly CFI for Pfizer Inc.?

Pfizer Inc. all-time high quarterly cash flow from investing activities is $9.67B

What is Pfizer Inc. quarterly CFI year-on-year change?

Over the past year, PFE quarterly cash flow from investing activities has changed by -$649.00M (-14.11%)

What is Pfizer Inc. TTM cash flow from investing activities?

The current TTM CFI of PFE is $3.54B

What is the all time high TTM CFI for Pfizer Inc.?

Pfizer Inc. all-time high TTM cash flow from investing activities is $6.15B

What is Pfizer Inc. TTM CFI year-on-year change?

Over the past year, PFE TTM cash flow from investing activities has changed by +$7.32B (+193.88%)
On this page